Technology
Health
Medical
Neurotrope
$7.039876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$7.03
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.07 (-0.99%) Today
$0.00 (0.00%) After Hours
Why Robinhood?
You can buy or sell Neurotrope and other stocks, options, ETFs, and crypto commission-free!
About
Neurotrope, Inc. Common Stock, also called Neurotrope, is a biopharmaceutical company, which engages in the pre-clinical and clinical development of its product candidates. Read More The company focuses on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease. It also develops bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X and Niemann-Pick Type C. The company was founded on January 11, 2011 and is headquartered in New York, NY.
Employees
6
Headquarters
New York, New York
Founded
2011
Market Cap
90.84M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
46.22K
High Today
$7.22
Low Today
$7.01
Open Price
$7.12
Volume
21.52K
52 Week High
$11.93
52 Week Low
$3.33
Collections
Technology
Health
Medical
Biopharmaceutical
Pharmaceutical
2013 IPO
US
North America
Price Paid on Robinhood
20% Higher
Right Now
52 Week Low
$3.33
Average Price Paid
$5.88
52 Week High
$11.93